secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2022-03-03T23:59:59+00:00
Accession:  0001104659-22-030112
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA Pharma prices $75M public offering of common stock and convertible preferred stock
--------------------------------------------------------------------------------

- Issued 21.7M common shares at $2.00/share and 15,800 Series A-1 convertible preferred shares at $2,000 each (each convertible into 1,000 common shares).
- Gross proceeds $75M; net proceeds expected ~$70M after underwriting discounts and expenses.
- Offering expected to close March 4, 2022; underwriters have 30-day option for up to 5.625M additional common shares.
- After offering, shares outstanding will be 50,868,668, excluding the underwriters' option.
- SVB Leerink and RBC Capital Markets acted as joint book-running managers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465922030112/0001104659-22-030112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465922030112/tm227839d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-030112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer